In this interview with Dr. Paul Thomas, I breakdown the critically flawed risk-benefit assessment the FDA relied upon to approve Pfizer's Covid vaccine for children 5-11 years of age.
In this interview with Dr. Paul Thomas, I breakdown the critically flawed risk-benefit assessment the FDA relied upon to approve Pfizer's Covid vaccine for children 5-11 years of age.